Results 191 to 200 of about 242,163 (312)

Bilirubin in Parkinson's disease: pathogenic mechanisms and therapeutic potentials. [PDF]

Front Neurosci
Wan Y, Xie C, Wang Q, Wang X.
europepmc   +1 more source

Nutritional Potential, Phytochemical Content, In Vivo Antioxidant, and Antanemic Potential of Musa paradisiaca Flower

Food Chemistry International, EarlyView.
After collecting Musa paradisiaca leaves, some were dried and others were used to produce aqueous extracts. The extracts and powders were characterized and then administered to rats made anaemic by PHZ. After 14 days of administration of the two samples, the rats were euthanized and it was observed that after 9 days of treatment, the aqueous extract ...
Josée Rebeca Nombo, Jethro Roland Misse Ngangue Ekwala, Somon Régine Tuem, Stéphano Tene Tambo, Merlin Ngafon Nchoutpouen, Valery Jean François Nsoga, Jules Christophe Koule Manz, Jordan Mekui Nwotue, Mathieu Ndomou   +8 more
wiley   +1 more source

Body‐integrated photonic biosensors: Illuminating the path to active healthcare

FlexMat, EarlyView.
Body‐integrated photonic biosensors are promising tools for active healthcare. These optical devices can be worn, implanted, or swallowed to monitor health signals continuously. This review introduces key sensing modalities, including fluorescence, colorimetry, SPR, LSPR, SERS, and light‐modulating materials.
Jiayue Gu, Xingming Wen, Qihang Yan, Yining Zhao, Linghao Yuan, Siyuan Chen, Yue Ma, Zhengyue Fang, Dong Lei, Yuxin Liu, Ze Xiong   +10 more
wiley   +1 more source

Treatment‐Related Adverse Events and Health‐Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

Head &Neck, EarlyView.
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell, E. C. Ward, L. R. Wishart, R. Perera, C. Barrett, K. A. Edmiston, E. Mitchell, A. Pigott, R. Pitt, K. Russell, B. A. Chan, R. Ladwa   +11 more
wiley   +1 more source

Hyaluronic Acid-Bilirubin Nanoparticles as a Tumor Microenvironment Reactive Oxygen Species-Responsive Nanomedicine for Targeted Cancer Therapy

Seonju Lee, Seon Ah Lee, Jongyoon Shinn, Yonghyun Lee College of Pharmacy, Ewha Womans University, Seoul, 03760, South KoreaCorrespondence: Yonghyun Lee, College of Pharmacy, Ewha Womans University, Seoul, 03760, South Korea, Email y.lee@ewha.ac ...
Lee S, Shinn J, Lee Y, Lee SA
core  

Case Report: Atypical hepatobiliary manifestations associated with erythrocyte membrane instability in glucose transporter type 1 deficiency syndrome. [PDF]

Front Pediatr
Lee H, Ryu SW, Hong J.
europepmc   +1 more source

Bilirubin-Driven Phenotype Identifies Higher Mortality Risk in Severe Alcohol-Associated Hepatitis. [PDF]

Gastro Hep Adv
Ayele TT, Tanaka T.
europepmc   +1 more source

Conjugated Hyperbilirubinemia in Early Infancy: Rethinking Diagnostic Cut-Offs-A Retrospective Analysis. [PDF]

Int J Neonatal Screen
Pfurtscheller D, Ganzer C, Suppan E, Winkler M, Schwaberger B, Sallmon L, Pichler G, Kohlmaier B.   +7 more
europepmc   +1 more source

Assessing the hepatic and renal parameters of breast cancer patient blood samples before and after chemotherapy. [PDF]

Toxicol Rep
Heilat GB, Alwidyan T, Alrosan AZ, Rataan AO, Alrosan K, Ahmad RB, Al-Kammash KR.   +6 more
europepmc   +1 more source

Diagnostic Utility of Next-Generation Sequencing for Unconjugated Hyperbilirubinemia in Children. [PDF]

Pediatr Gastroenterol Hepatol Nutr
Kim HJ.
europepmc   +1 more source